基于胰高血糖素类肽-1的抗肥胖药物的通用事先授权模板:肥胖医学协会提案

{"title":"基于胰高血糖素类肽-1的抗肥胖药物的通用事先授权模板:肥胖医学协会提案","authors":"Harold Edward Bays , Carolynn Francavilla Brown , Angela Fitch","doi":"10.1016/j.obpill.2023.100079","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100977,"journal":{"name":"Obesity Pillars","volume":"8 ","pages":"Article 100079"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Universal Prior Authorization Template for glucagon like peptide-1 based anti-obesity medications: An Obesity Medicine Association proposal\",\"authors\":\"Harold Edward Bays , Carolynn Francavilla Brown , Angela Fitch\",\"doi\":\"10.1016/j.obpill.2023.100079\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100977,\"journal\":{\"name\":\"Obesity Pillars\",\"volume\":\"8 \",\"pages\":\"Article 100079\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity Pillars\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667368123000256\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Pillars","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667368123000256","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}